Search - tctmd.com

Displaying 21 - 40 of 322

Sort: Relevancy | Date

News Daily News

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

Yael L. Maxwell

May 05, 2025

News Conference News HRS 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

Todd Neale

April 28, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Daily News

Black Adults Face CV Mortality Beyond Their Predicted Risk

Caitlin E. Cox

April 18, 2025

News Daily News

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

Yael L. Maxwell

March 24, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

Better Cardiovascular Health May Stave Off Degenerative Brain Disease

Todd Neale

March 13, 2025

Genetic Risk Score for Endothelial Cell Dysfunction Identifies Patients at Risk

News Daily News

Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care

Michael O'Riordan

February 27, 2025

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown

February 14, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Michael O'Riordan

December 18, 2024

News Daily News

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Yael L. Maxwell

December 17, 2024

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Daily News

Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains

L.A. McKeown

October 22, 2024

News Daily News

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Todd Neale

October 15, 2024

News Daily News

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

L.A. McKeown

October 15, 2024

News Daily News

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Michael O'Riordan

October 03, 2024

Advertisement

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

GLP-1 Drugs May Have Role in Secondary Prevention of AF

April 2025 Dispatch for the CV Team

Black Adults Face CV Mortality Beyond Their Predicted Risk

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

March 2025 Dispatch for the CV Team

Better Cardiovascular Health May Stave Off Degenerative Brain Disease

Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

December 2024 Dispatch for the CV Team

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content